Guardian Biomedical Introduces PREVIO
PREVIO monitors physiological signals to identify early deterioration and risk before symptoms or emergencies occur.
THE PROBLEM
Across healthcare, senior care, athletics, and preventive health, deterioration rarely happens without warning. Stability declines, recovery slows, and internal stress accumulates long before an emergency occurs.
Today’s tools detect events after they happen.
PREVIO is being built to detect risk before it becomes visible.
.jpg)
PREVIO serves organizations that operate at the intersection of healthcare delivery, life sciences research, and population health management.
.svg){kind=small}
Our Team
Guardian BioMedical is working with experienced advisors across FDA regulatory pathways, medical device cybersecurity, enterprise healthcare commercialization, and applied systems engineering to guide PREVIO
Manny Manzel
Founder & CEO
Founder of Guardian BioMedical. Leads product vision, architecture, and strategy.
PREVIO is being built by a multidisciplinary engineering team spanning hardware, embedded systems, cloud infrastructure, and applied machine learning, supported by domain experts in regulatory strategy and clinical systems.
.jpg)
.svg){kind=small}
.svg){kind=small}